Momentum seems to be building behind biotech financings as the first month of 2023 draws to a close, with a respectable raise for cancer start-up Synnovation Therapeutics
2023 was a tough year for biotechs with declines in private fundraising and public listings, but the UK industry stood up well under the pressure, according to new figures
Our round-up of recent biotech financings is headed by a massive $1.25 billion round for genetic medicines specialist BridgeBio Pharma, with smaller rounds for Tr1X, Coman
Quantifying the Success of Your Patient Engagement Activities to Satisfy Regulatory Requirements, Present ROI to Stakeholders, and Above All Improve the Patient Experience
Editor-in-chief Jonah Comstock sat down with Jeff Smith, chief research officer at Precision BioSciences, on the side lines of the JP Morgan Healthcare Conference in San Francisco to discus